Search research articles
Contact Us
Filters
Showing results (941-950 of 1,199) with videos related to
Page
of 120
Sort By:
Toxicology
|
September 19, 2025
Reflections on the NIEHS Virtual Consortium funding mechanism (ViCTER) and what it has taught us about the future of transdisciplinary science
Almudena Veiga-Lopez, Hanna E Stevens, Matthew Rand, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 1, 2007
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis
H Butzkueven, J Chapman, E Cristiano, et al.
Nature Communications
|
August 6, 2021
The middle lipin domain adopts a membrane-binding dimeric protein fold
Weijing Gu, Shujuan Gao, Huan Wang, et al.
Nucleic Acids Research
|
June 23, 2009
Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays
Jochen B Geigl, Anna C Obenauf, Julie Waldispuehl-Geigl, et al.
Journal of Medicinal Chemistry
|
May 18, 2001
Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE
I J De Esch, J E Mills, T D Perkins, et al.
Blood Advances
|
October 30, 2020
Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation
Laura R E Becher, Wendy K Nevala, Shari Lee Sutor, et al.
Neuroscience Letters
|
April 5, 2003
Apolipoprotein E (apoE) uptake and distribution in mammalian cell lines is dependent upon source of apoE and can be monitored in living cells
M C Ljungberg, A Asuni, J Pearce, et al.
Rheumatology (Oxford, England)
|
February 12, 2022
Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial
Elizabeth R Volkmann, Michael Kreuter, Anna M Hoffmann-Vold, et al.
Journal of Medicinal Chemistry
|
April 10, 1999
Characterization of the binding site of the histamine H3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)-cyclopropylamine
I J De Esch, R C Vollinga, K Goubitz, et al.
Pharmacopsychiatry
|
September 19, 2002
Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study
D Riemann, U Voderholzer, S Cohrs, et al.
Page
of 120
Search research articles
Search
Showing results (941-950 of 1,199) with videos related to
Sort By:
Page
of 120
Toxicology
|
September 19, 2025
Reflections on the NIEHS Virtual Consortium funding mechanism (ViCTER) and what it has taught us about the future of transdisciplinary science
Almudena Veiga-Lopez, Hanna E Stevens, Matthew Rand, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 1, 2007
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis
H Butzkueven, J Chapman, E Cristiano, et al.
Nature Communications
|
August 6, 2021
The middle lipin domain adopts a membrane-binding dimeric protein fold
Weijing Gu, Shujuan Gao, Huan Wang, et al.
Nucleic Acids Research
|
June 23, 2009
Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays
Jochen B Geigl, Anna C Obenauf, Julie Waldispuehl-Geigl, et al.
Journal of Medicinal Chemistry
|
May 18, 2001
Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE
I J De Esch, J E Mills, T D Perkins, et al.
Blood Advances
|
October 30, 2020
Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation
Laura R E Becher, Wendy K Nevala, Shari Lee Sutor, et al.
Neuroscience Letters
|
April 5, 2003
Apolipoprotein E (apoE) uptake and distribution in mammalian cell lines is dependent upon source of apoE and can be monitored in living cells
M C Ljungberg, A Asuni, J Pearce, et al.
Rheumatology (Oxford, England)
|
February 12, 2022
Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial
Elizabeth R Volkmann, Michael Kreuter, Anna M Hoffmann-Vold, et al.
Journal of Medicinal Chemistry
|
April 10, 1999
Characterization of the binding site of the histamine H3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)-cyclopropylamine
I J De Esch, R C Vollinga, K Goubitz, et al.
Pharmacopsychiatry
|
September 19, 2002
Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study
D Riemann, U Voderholzer, S Cohrs, et al.
Page
of 120